美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
40967 A III 2024/12/19 INVOX BELGIUM N.V. SOFTHALER SMI
40981 A II 2024/12/19 AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) SACUBITRIL/VALSARTAN CRYSTALLINE
40999 A II 2024/12/19 SICHUAN KELUN PHARMACEUTICAL CO LTD ENZALUTAMIDE
41005 A II 2024/12/19 ZHEJIANG KINGLAND PHARMACEUTICAL CO LTD ALOGLIPTIN BENZOATE
41021 A II 2024/12/19 REGEN-AGEEK (HAINING) BIOTECHNOLOGY CO LTD HUMAN UMBILICAL MESENCHYMAL STEM CELL EXOSOMES
40305 A II 2024/12/19 WANYANG HENGSHUI PHARMACEUTICAL CO LTD ANASTROZOLE
41041 A IV 2024/12/19 ANMOL CHEMICALS PVT LTD ALUMINUM SULFATE USP
41042 A IV 2024/12/19 ANMOL CHEMICALS PVT LTD COPPER SULFATE PENTAHYDRATE BP
40626 A II 2024/12/18 PHARMAZELL GMBH URSODIOL
40959 A II 2024/12/18 CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD POSACONAZOLE
40968 A II 2024/12/18 CHANGZHOU PHARMACEUTICAL FACTORY BICTEGRAVIR SODIUM
40992 A II 2024/12/18 ALIVUS LIFE SCIENCES LTD TIVOZANIB HYDROCHLORIDE
41010 A II 2024/12/18 ACROBIOSYSTEMS CO LTD GMP GRADE IL2 PROTEIN (LIQUID) (GMP-L02H14F002)
40674 A II 2024/12/17 MIRUS BIO LLC REVIT GMP AAV ENHANCER
40829 A II 2024/12/17 HUADONG MEDICINE (XI'AN) BODYGUARD PHARMACEUTICAL CO LTD TOPIRAMATE
40929 A IV 2024/12/17 GM CHEMICAL HYPROMELLOSE ACETATE SUCCINATE USP/NF
41017 A II 2024/12/17 CTX LIFESCIENCES PVT LTD SAXAGLIPTIN INTERMEDIATE STAGE-I [CAS # 709031-43-6]
38684 A II 2024/12/17 MIRUS BIO LLC TRANSIT-VIRUSGEN GMP TRANSFECTION REAGENT
39562 A II 2024/12/16 ZAKLADY FARMACEUTYCZNE POLPHARMA SA BARICITINIB
41147 A III 2024/12/16 SHANGHAI YINGFA MEDICAL COMPOSITE MATERIALS CO LTD POLYESTER FILM COATED WITH ALUMINUM

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files